Watchlist Price Alert

Zynerba Pharmaceuticals I... (ZYNE)

NASDAQ: ZYNE · Real-Time Price · USD

1.30

0.03 (2.36%)

At close: Oct 10, 2023, 10:00 PM

Zynerba Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-35.04M	-37.31M	-51.34M	-32.94M	-39.91M	-32.01M	-23.39M
Depreciation & Amortization	219.28K	247.14K	207.03K	133.88K	99.57K	94.21K	75.3K
Stock-Based Compensation	4.33M	5.81M	5.18M	5.56M	6.63M	5.65M	3.27M
Other Working Capital	7.39M	-1.48M	6.78M	-7.78M	-314.5K	-1.06M	-1.54M
Other Non-Cash Items	n/a	n/a	n/a	n/a	n/a	n/a	99.15K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	7.46M	-2.21M	4.64M	-7.57M	788.51K	428.79K	-493.47K
Operating Cash Flow	-23.03M	-33.46M	-41.31M	-34.82M	-32.4M	-25.84M	-20.44M
Capital Expenditures	-154.1K	-47.57K	-445.31K	-129.39K	-286.66K	-115.36K	-109.63K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-154.1K	-47.57K	-445.31K	-129.39K	-286.66K	-115.36K	-109.63K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	6.01M	42.16M	30.85M	45.25M	29.94M	57.5M	10M
Financial Cash Flow	6.01M	42.16M	30.85M	45.25M	29.94M	57.5M	10M
Net Cash Flow	-17.17M	8.65M	-10.91M	10.3M	-2.75M	31.54M	-10.55M
Free Cash Flow	-23.18M	-33.51M	-41.76M	-34.95M	-32.68M	-25.96M	-20.55M